Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon α-2B for Advanced Hepatocellular Carcinoma

被引:0
|
作者
Kasai, Kazuhiro
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S1035 / S1036
页数:2
相关论文
共 50 条
  • [1] Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma
    Kasai, Kazuhiro
    Ushio, Akira
    Kasai, Yukiho
    Sawara, Kei
    Miyamoto, Yasuhiro
    Oikawa, Kanta
    Kuroda, Hidekatsu
    Takikawa, Yasuhiro
    Suzuki, Kazuyuki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (03) : 221 - 229
  • [2] Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma
    Kazuhiro Kasai
    Akira Ushio
    Yukiho Kasai
    Kei Sawara
    Yasuhiro Miyamoto
    Kanta Oikawa
    Hidekatsu Kuroda
    Yasuhiro Takikawa
    Kazuyuki Suzuki
    [J]. International Journal of Clinical Oncology, 2011, 16 : 221 - 229
  • [3] Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma.
    Kasai, Kazuhiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [4] Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma
    Kasai, Kazuhiro
    Sawara, Kei
    Suzuki, Kazuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Evaluation of Newly Developed Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon α-2B for Advanced Hepatocellular Carcinoma With Portal Venous Invasion
    Kasai, Kazuhiro
    Sawara, Kei
    Suzuki, Kazuyuki
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S812 - S812
  • [6] Evaluation of Newly Developed Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon α-2B for Advanced Hepatocellular Carcinoma with Portal Venous Invasion
    Sawara, Kei
    Kasai, Kazuhiro
    Suzuki, Kazuyuki
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A860 - A860
  • [7] Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion: preliminary results
    Kasai, Kazuhiro
    Kuroda, Hidekatsu
    Ushio, Akira
    Sawara, Kei
    Takikawa, Yasuhiro
    Suzuki, Kazuyuki
    [J]. HEPATOLOGY RESEARCH, 2009, 39 (02) : 117 - 125
  • [8] Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon a-2b for advanced hepatocellular carcinoma with portal venous invasion
    Kasai, Kazuhiro
    Ushio, Akira
    Kasai, Yukiho
    Sawara, Kei
    Miyamoto, Yasuhiro
    Oikawa, Kanta
    Kuroda, Hidekatsu
    Takikawa, Yasuhiro
    Suzuki, Kazuyuki
    [J]. CANCER, 2012, 118 (13) : 3302 - 3310
  • [9] Effective Treatment for Advanced Hepatocellular Carcinoma with Portal Venous Invasion using a Combination Therapy of Intra-arterial 5-Fluorouracil and Subcutaneous Pegylated-interferon-alpha-2b
    Mawatari, Hironori
    Kirikoshi, Hiroyuki
    Yoneda, Masato
    Higurashi, Takuma
    Fujita, Koji
    Saito, Satoru
    Inamori, Masahiko
    Takahashi, Hirokazu
    Abe, Yasunobu
    Kubota, Kensuke
    Nakajima, Atsushi
    [J]. HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1776 - 1777
  • [10] Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for hiqhly advanced hepatocellular carcinoma
    Damdinsuren, Bazarragchaa
    Nagano, Hiroaki
    Monden, Morito
    [J]. HEPATOLOGY RESEARCH, 2007, 37 : S238 - S250